All News about Alzamend Neuro Inc![]() ![]() ![]()
Alzamend Neuro Seeks FDA Nod For Dementia Immunotherapy Study
September 29, 2022
Via Benzinga
![]() ![]() ![]()
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via Benzinga
![]()
Alzamend Neuro Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
September 22, 2022
From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() From Alzamend Neuro, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|